Skip to content
SEARCH
Investing
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
Health
Entertainment
Real Estate
Cannabis
ESG
Financial
Industrials
Food & Beverage
Search
SEARCH FOR AN ARTICLE
Search
Search
Investing
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
Health
Entertainment
Real Estate
Cannabis
ESG
Financial
Industrials
Food & Beverage
SEARCH
Home
Fezolinetant
Fezolinetant
Health
U.S. FDA Accepts Fezolinetant New Drug Application from Astellas
August 19, 2022
LATEST NEWS
Investing
Domino’s Pizza Stock Appears Undervalued Ahead of Monday’s Earnings
Investing
GE Healthcare Partnerships Aim to Enhance Patient Outcomes
Investing
Retail Sales Surge: Boost for GM’s Q1 Earnings?
Investing
Navigating Merck Stock Before Q1 Earnings
Investing
Analyst Predicts 22% Upside for Meta Platforms